Le Lézard
Classified in: Health, Business
Subject: CXP

Leading Netherlands Hospital Adopts the EarlySense System for Continuous Patient Monitoring


WOBURN, Massachusetts, Sept. 12, 2018 /PRNewswire/ -- EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced today a comprehensive implementation by Franciscus Gasthuis & Vlietland (Rotterdam), a leading hospital in the Netherlands. The hospital installed EarlySense's continuous monitors in its 28-bed pulmonology ward following a successful evaluation of EarlySense's sensors by the hospital's nursing department.

Leveraging big data analytics, the EarlySense system will enable hospital staff to continuously and accurately monitor patient heart rate, respiratory rate and movement. This consistent stream of patient data will aid the nursing staff with early detection of patient deterioration, helping in preventing adverse events including patient falls.

"We are dedicated to providing our patients with the highest level of care, and equipping our nursing staff with advanced technology to help them succeed in their roles," said Lex Kahlman, Care Manager Pulmonology at Franciscus Gasthuis & Vlietland. "Preventing patient deterioration and falls is one of our key patient health objectives, as many of our patients are elderly and prone to falls. The EarlySense continuous monitoring system is a powerful tool that will help us mitigate this risk, and we are excited to add it to our ward as part of our total safety initiative."

Used worldwide in hospitals, rehab and skilled nursing facilities, the EarlySense continuous monitoring system leverages advanced algorithms to notify nurses of potentially adverse changes in patient vital signs, sending alerts to their pagers and to the central display station.  The FDA-cleared and CE-approved solution has been clinically proven to help prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions.

"Franciscus Gasthuis & Vlietland is the latest hospital to join our growing list of global customers and we are proud to be included in their vision for patient safety," said Yfat Scilaom, VP of International Sales and Marketing at EarlySense. "Continuous monitoring solutions are coming closer to becoming a standard of care across the health continuum, and we are proud to see EarlySense technology continue to help patients and healthcare teams across the world."

View a video about this implementation here: https://youtu.be/sbfmZaExQyo.

About Franciscus Gasthuis & Vlietland

Franciscus Gasthuis & Vlietland is part of the group of Top Clinical Hospitals in the Netherlands. With focus on providing high quality care, the hospital is a recognized Medical Training and Research facility. Professional and motivated staff are the spill of the institution with 5 locations, 4,600 employees and more than 350 medical specialists. https://www.franciscus.nl/

About EarlySense

EarlySense® is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals, post-acute care facilities, and homes, EarlySense assists clinicians in early detection of patient deterioration. The solution has been proven to help prevent adverse events, including code blue events which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions. EarlySense's FDA-cleared solutions leverage Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes. The company has partnered with leading global technology companies including Samsung, Welch Allyn, iFit and Beurer. EarlySense is based in Ramat Gan, Israel and Woburn, Massachusetts. For more information, visit www.earlysense.com.

Follow EarlySense on LinkedInTwitter and Facebook.

Media Contact:
Ellie Hanson
Finn Partners
+1-929-222-8006
[email protected]

Company Contact:
Hila Peleg
+972-54-527-3117
[email protected]

SOURCE EarlySense; Franciscus Gasthuis & Vlietland


These press releases may also interest you

at 06:45
The "Global Pediatric Interventional Cardiology Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to  ResearchAndMarkets.com's offering. The Global Pediatric...

at 06:30
The "Sample Preparation Market by Product (Workstation, Instrument {Pipette, Washer, Centrifuge, Grinder}, Consumable {Kits, Filters, Plates}) Technique (Solid Phase Extraction, Purification) Application (Drug Discovery, Diagnostic) - Global Forecast...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...



News published on and distributed by: